Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 806,678 | 703,926 | 701,054 | 177,254 | 1,034,334 |
| Marketable Securities | 476,324 | 518,731 | 530,062 | 146,401 | 126,211 |
| Receivables | 206,606 | 163,608 | 140,046 | 130,362 | 82,200 |
| Inventories | 80,427 | 82,215 | 69,424 | 61,724 | 53,673 |
| TOTAL | $1,606,627 | $1,504,858 | $1,484,318 | $553,936 | $1,319,978 |
| Non-Current Assets | |||||
| PPE Net | 456,455 | 463,437 | 465,476 | 455,325 | 370,532 |
| Intangibles | 2,109,332 | 2,342,787 | 2,365,422 | 2,346,747 | 44,385 |
| Other Non-Current Assets | 181,956 | 156,653 | 145,909 | 149,760 | 24,373 |
| TOTAL | $2,747,743 | $2,962,877 | $2,976,807 | $2,951,832 | $439,290 |
| Total Assets | $4,354,370 | $4,467,735 | $4,461,125 | $3,505,768 | $1,759,268 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,319 | 1,319 | 24,565 | 834 | 316,244 |
| Accounts payable and accrued liabilities | 26,061 | 30,998 | 38,048 | 25,973 | 19,158 |
| Accrued Expenses | 182,945 | 139,505 | 166,596 | 193,329 | 136,000 |
| Other current liabilities | 31,761 | 40,581 | 5,709 | 8,467 | 9,290 |
| TOTAL | $252,832 | $222,274 | $243,581 | $236,494 | $480,692 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,643 | 22,944 | N/A | 24,032 | 24,254 |
| Other Non-Current Liabilities | 1,741,795 | 1,711,324 | 1,679,891 | 957,181 | 506,038 |
| TOTAL | $1,764,438 | $1,734,268 | $1,679,891 | $981,213 | $530,292 |
| Total Liabilities | $2,017,270 | $1,956,542 | $1,923,472 | $1,217,707 | $1,010,984 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 150,424 | 150,167 | 149,746 | 147,968 | 129,832 |
| Common Shares | 1,505 | 1,501 | 1,495 | 1,477 | 1,299 |
| Retained earnings | -1,531,479 | -1,311,595 | -1,225,453 | -1,119,756 | -1,197,701 |
| Other shareholders' equity | 1,084 | 1,489 | -1,717 | -100 | -360 |
| TOTAL | $2,337,100 | $2,511,193 | $2,537,653 | $2,288,061 | $748,284 |
| Total Liabilities And Equity | $4,354,370 | $4,467,735 | $4,461,125 | $3,505,768 | $1,759,268 |